We are live on
!
Find out more
GCM
Ghisallo Capital Management Portfolio holdings
AUM
$5.1B
1-Year Est. Return
39.13%
This Fund
S&P 500
This Quarter
Est. Return
+15.09%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
–
AUM
$5.1B
AUM Growth
+$1.47B
(+40%)
Cap. Flow
+$410M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
42.59%
Holding
458
New
148
Increased
12
Reduced
51
Closed
123
Avg Time Held
1.3
quarters
Top 10 Avg Time Held
0.3
quarters
Top 20 Avg Time Held
0.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$965M |
| 2 |
Digital Realty Trust
DLR
|
+$229M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$144M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$143M |
| 5 |
Super Micro Computer
SMCI
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$102M |
| 2 |
NVIDIA
NVDA
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$92.5M |
| 4 |
GlobalFoundries
GFS
|
+$80.1M |
| 5 |
Medline Inc
MDLN
|
+$62.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 29.61% |
| 2 | Miscellaneous | 19.42% |
| 3 | Communication Services | 10.49% |
| 4 | Technology | 8.11% |
| 5 | Healthcare | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Denali Therapeutics
DNLI
$2.94B
| $2.57M | 0.05% |
100,000
| – | – |
2025 Q4
2 quarters
|
|
177
Pioneer Acquisition I Corp
PACH
$295M
| $2.55M | 0.05% |
250,000
| – | – |
2025 Q3
3 quarters
|
|
178
Daedalus Special Acquisition Corp
DSAC
| $2.52M | 0.05% |
250,000
| – | – |
2026 Q1
1 quarter
|
|
|
CAES
179
Cantor Equity Partners VII
CAES
$319M
| $2.52M | 0.05% |
+250,000
| New | +$2.52M |
2026 Q2
0 quarters
|
|
180
Archimedes Tech SPAC Partners III
ARCI
| $2.5M | 0.05% |
250,000
| – | – |
2026 Q1
1 quarter
|
|
181
General Purpose Acquisition Corp
GPAC
$297M
| $2.5M | 0.05% |
250,000
| – | – |
2026 Q1
1 quarter
|
|
182
Activate Energy Acquisition Corp
AEAQ
| $2.5M | 0.05% |
250,000
| – | – |
2026 Q1
1 quarter
|
|
|
AAC.U
183
Ares Acquisition Corporation III Units
AAC.U
| $2.5M | 0.05% |
+250,000
| New | +$2.51M |
2026 Q2
0 quarters
|
|
|
WLCOU
184
Wilco 63 Corporation Units
WLCOU
$198M
| $2.49M | 0.05% |
+250,000
| New | +$2.48M |
2026 Q2
0 quarters
|
|
185
Soren Acquisition Corp
SORN
| $2.48M | 0.05% |
250,000
| – | – |
2026 Q1
1 quarter
|
|
186
Cambridge Acquisition Corp
CAQ
$313M
| $2.48M | 0.05% |
+250,000
| New | +$2.47M |
2026 Q2
0 quarters
|
|
187
HMH Holding Inc
HMH
$227M
| $2.34M | 0.05% |
+125,000
| New | +$2.56M |
2026 Q2
0 quarters
|
|
188
EagleRock Land
EROK
$539M
| $2.34M | 0.05% |
+110,000
| New | +$2.38M |
2026 Q2
0 quarters
|
|
189
Avalyn Pharma
AVLN
$1.05B
| $2.3M | 0.05% |
+70,000
| New | +$2.02M |
2026 Q2
0 quarters
|
|
190
Chenghe Acquisition III Co
CHEC
| $2.29M | 0.04% |
225,000
| – | – |
2025 Q4
2 quarters
|
|
191
Altimmune
ALT
$473M
| $2.28M | 0.04% |
+750,000
| New | +$2.24M |
2026 Q2
0 quarters
|
|
192
RMG ML Sports Holdings Unit
SHOTU
$204M
| $2.25M | 0.04% |
+225,000
| New | +$2.25M |
2026 Q2
0 quarters
|
|
193
Nektar Therapeutics
NKTR
$1.29B
| $2.23M | 0.04% |
+32,000
| New | +$2.34M |
2026 Q2
0 quarters
|
|
194
Lineage Inc
LINE
$7.85B
| $2.16M | 0.04% |
50,000
-50,100
| -50% | -$1.97M |
2024 Q3
7 quarters
|
|
195
Guardian Pharmacy Services
GRDN
$2.52B
| $2.09M | 0.04% |
50,000
-75,000
| -60% | -$2.9M |
2024 Q3
7 quarters
|
|
196
Aldabra 4 Liquidity Opportunity Vehicle Inc Units
ALOVU
| $2.09M | 0.04% |
200,000
| – | – |
2026 Q1
1 quarter
|
|
197
WhiteHawk Minerals Corp
WHK
$703M
| $2.09M | 0.04% |
+75,000
| New | +$2.04M |
2026 Q2
0 quarters
|
|
198
Blue Water Acquisition Corp III
BLUW
$336M
| $2.06M | 0.04% |
200,000
| – | – |
2025 Q3
3 quarters
|
|
199
NervGen Pharma
NGEN
$175M
| $2.06M | 0.04% |
+1,000,000
| New | +$3.1M |
2026 Q2
0 quarters
|
|
200
Wen Acquisition Corp
WENN
$391M
| $2.06M | 0.04% |
200,000
| – | – |
2025 Q3
3 quarters
|
|
Similar funds
KACA
MRCP
CFO
YCM
BPCE
GIBU
ACM
BMO
Ghisallo Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Ghisallo Capital Management held 458 positions worth $5.1B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Ghisallo Capital Management deployed $410M of net new capital in Q2 2026, opening 148 new positions and adding to 12 existing holdings. Its largest new stake was SpaceX: 5,678,145 shares worth $970M.
By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Communication Services.
On the sell side, the largest reduction was Medline Inc, an estimated $62.3M trimmed.
- Ghisallo Capital Management's largest Q2 2026 buy was SpaceX: 5,678,145 shares worth $970M.
- Ghisallo Capital Management added most to Diamondback Energy in Q2 2026, an estimated $29.1M increase.
- Ghisallo Capital Management's biggest Q2 2026 reduction was Medline Inc, cutting an estimated $62.3M.
- Ghisallo Capital Management fully exited Tesla in Q2 2026, selling an estimated $102M.
- Ghisallo Capital Management's ten largest holdings make up 43% of its $5.1B portfolio in Q2 2026.
- Ghisallo Capital Management opened 148 new positions and closed 123 in Q2 2026.
- Ghisallo Capital Management's portfolio value rose 40% quarter-over-quarter to $5.1B.
Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.